BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 110 filers reported holding BIONTECH SE in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,637,570 | +108.9% | 455,918 | +139.8% | 0.06% | +106.5% |
Q1 2024 | $17,536,910 | -66.3% | 190,102 | -60.3% | 0.03% | -70.8% |
Q3 2023 | $52,009,010 | +38.2% | 478,728 | +37.3% | 0.11% | +29.3% |
Q2 2023 | $37,626,988 | +120.6% | 348,624 | +207.1% | 0.08% | +74.5% |
Q4 2022 | $17,054,176 | +1513.5% | 113,528 | +1348.6% | 0.05% | +1466.7% |
Q3 2022 | $1,057,000 | +42.6% | 7,837 | +57.6% | 0.00% | +50.0% |
Q2 2022 | $741,000 | -96.0% | 4,973 | -95.4% | 0.00% | -96.6% |
Q1 2022 | $18,500,000 | -34.5% | 108,468 | +4.8% | 0.06% | -50.8% |
Q3 2021 | $28,242,000 | +870.5% | 103,455 | +695.8% | 0.12% | +742.9% |
Q2 2021 | $2,910,000 | -84.2% | 13,000 | -92.3% | 0.01% | -84.6% |
Q1 2021 | $18,453,000 | +115.6% | 169,000 | +61.0% | 0.09% | +89.6% |
Q4 2020 | $8,560,000 | -70.0% | 105,000 | -74.5% | 0.05% | -76.9% |
Q3 2020 | $28,496,000 | +31.1% | 411,619 | +26.3% | 0.21% | +10.1% |
Q2 2020 | $21,742,000 | – | 325,785 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 1,003,640 | $149,643,000 | 20.73% |
Bill & Melinda Gates Foundation | 148,674 | $22,200,000 | 17.06% |
Quinn Opportunity Partners LLC | 300,721 | $44,838,000 | 3.90% |
PARUS FINANCE (UK) Ltd | 42,953 | $6,404,000 | 3.81% |
Renaissance Capital LLC | 36,476 | $5,439,000 | 2.90% |
Baader Bank Aktiengesellschaft | 224,800 | $33,520,000 | 2.58% |
Tri Locum Partners LP | 39,663 | $5,914,000 | 2.42% |
MARK ASSET MANAGEMENT LP | 61,734 | $9,205,000 | 2.22% |
Franchise Capital Ltd | 43,650 | $6,508,000 | 2.18% |
Boston Common Asset Management, LLC | 283,776 | $42,311,000 | 2.11% |